Steris (STE) Tops Q1 EPS by 14c ; Offers Guidance

Steris (NYSE: STE) reported Q1 EPS of $2.74, $0.14 better than the analyst estimate of $2.60. Revenue for the quarter came in at $1.48 billion versus the consensus estimate of $1.48 billion.

GUIDANCE:

Steris sees FY2025 EPS of $9.90-$10.15, versus the consensus of $9.06.

For earnings history and earnings-related data on Steris (STE) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Mizuho: 'we believe CMG's cycle of lower margin revisions remains in the rear-view mirror'
• JPMorgan Downgrades Li Ning Co. Ltd. (2331:HK) (LNNGF) to Neutral